Skip to content
Toggle navigation
About
Who We Are
Our Focus
Leadership
Board
of Directors
Therapeutic Areas
Progressive
Pulmonary Disease
Malabsorption
Syndromes
Patient Focus
Cystic Fibrosis
Other Rare
Disease Areas
Product Development
News & Publications
Press Releases
Publications
& Abstracts
Contact
About
Who We Are
Our Focus
Leadership
Board
of Directors
Therapeutic Areas
Progressive
Pulmonary Disease
Malabsorption
Syndromes
Patient Focus
Cystic Fibrosis
Other Rare
Disease Areas
Product Development
News & Publications
Press Releases
Publications
& Abstracts
Contact
News &
Publications
Press Releases
Publications
& Abstracts
< Back to Press Releases
October 15, 2018
Cystic Fibrosis News Today: Synspira’s Candidate SNSP113 Wins FDA Orphan Designation to Treat Bacterial Infections in Cystic Fibrosis
Read on
Cystic Fibrosis News Today